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Bile-salt activated carboxylic ester lipase (CEL) is a major triglyceride, cholesterol ester and vitamin ester hydrolytic enzyme
contained within pancreatic and lactating mammary gland secretions. Bioinformatic methods were used to predict the amino
acid sequences, secondary and tertiary structures and gene locations for CEL genes, and encoded proteins using data from several
vertebrate genome projects. A proline-rich and O-glycosylated 11-amino acid C-terminal repeat sequence (VNTR) previously
reported for human and other higher primate CEL proteins was also observed for other eutherian mammalian CEL sequences
examined. In contrast, opossum CEL contained a single C-terminal copy of this sequence whereas CEL proteins from platypus,
chicken, lizard, frog and several ﬁsh species lacked the VNTR sequence. Vertebrate CEL genes contained 11 coding exons.
Evidence is presented for tandem duplicated CEL genes for the zebraﬁsh genome. Vertebrate CEL protein subunits shared 53–
97% sequence identities; demonstrated sequence alignments and identities for key CEL amino acid residues; and conservation of
predicted secondary and tertiary structures with those previously reported for human CEL. Phylogenetic analyses demonstrated
the relationships and potential evolutionary origins of the vertebrate CEL family of genes which were related to a nematode
carboxylesterase (CES)g e n ea n dﬁ v em a m m a l i a nCES gene families.
1.Introduction
Bile-salt activated carboxylic ester lipase (CEL; also desig-
nated as cholesterol esterase and lysophospholipase) is a ma-
jor triglyceride, cholesterol ester and vitamin ester hydrolytic
enzymecontainedwithinpancreaticandlactatingmammary
gland secretions [5–10]. CEL is also secreted by the liver and
is localized in plasma where it contributes to chylomicron
assembly and secretion, the selective uptake of cholesteryl
esters in HDL by the liver, LDL lipid metabolism, and reverse
cholesterol transport [11–14]. Plasma CEL may also con-
tribute to endothelial cell proliferation, the induction of vas-
cular smooth muscle proliferation, and thrombus formation
throughinteractionwithplateletCXCR4[15].Morerecently,
CEL expression has been reported in human pituitary glands
where it may function in regulating hormone secretion in
association with the CEL hydrolytic activity of ceramides
[16].
Structures for several human and animal CEL genes and
cDNA sequences have been determined, including human
(Homo sapiens)[ 7, 17–19], gorilla (Gorilla gorilla)[ 20],
mouse (Mus musculus)[ 21–23], rat (Rattus norvegicus)[ 24–
26],andcow(Bostaurus)CELgenes[1,27].ThehumanCEL
gene comprises 11 exons and is localized on chromosome 9
[28]. Several Alu repetitive sequence elements and putative
transcription factor binding sites have been identiﬁed in the
5 -untranslated (UTR) region, including pancreatic-speciﬁc
bindingsites,whichcontributetoahighlevelofexpressionin
theexocrinepancreas[17,29,30].Exon11ofthehumanCEL
gene encodes a variable number of tandem repeat sequences2 Cholesterol
region (VNTR) (17 repeats are most common) which is
highly polymorphic in human populations and contributes
to plasma cholesterol and lipid composition [13]. Moreover,
rare CEL gene defects in this region are responsible for a
monogenically derived diabetes condition called maturity-
onset diabetes of the young type 8 (MODY8), also known as
diabetesandpancreaticexocrinedysfunction(DPED),which
causes a defect in insulin secretion [31, 32].
Human CEL is expressed predominantly in the lactating
mammary gland and beta cells of the exocrine pancreas,
where the enzyme contributes signiﬁcantly to triglyceride,
cholesterol ester and vitamin ester metabolism [5–10]. CEL
also promotes large chylomicron production in the intestine,
and its presence in plasma supports interactions with cho-
lesterol and oxidized lipoproteins [11] which may inﬂu-
ence atherosclerosis progression [12]. CEL expression has
also been reported in the human pituitary gland, and a pos-
sible role for CEL in the regulation of hormone secretion
and ceramide metabolism has been described [16]. Studies
of Cel−/Cel− knock out mice have shown that other enzymes
besidesCELarepredominantlyresponsibleforthehydrolysis
of dietary cholesteryl esters, retinyl esters, and triglycerides
[33]. Metabolic studies of Cel-null mice however have re-
ported that a lack of CEL activity causes an incomplete di-
gestion of milk fat and lipid accumulation by enterocytes in
the ileum of neonatal mice which suggests a major role for
this enzyme in triglyceride hydrolysis in breast-fed animals
[9, 34]. Moreover, reverse cholesterol transport is elevated in
carboxylesterlipase-knockoutmicewhichsupportsasignifi-
cant role for this enzyme in the biliary disposal of cholesterol
from the body [14].
A CEL-like gene (designated as CELL) has also been
identiﬁed on human and gorilla chromosome 9, about 10
kilobases downstream of CEL, which is transcribed in many
tissues of the body but lacks exons 2–7 and is unlikely to be
translated into protein [17, 20, 35]. The CELL pseudogene
gene duplication apparently occurred prior to the separation
of Hominidae (man, chimpanzee, gorilla, and orangutan)
from Old World monkeys (macaque) with CELL being re-
stricted to genomes of man and the great apes [20].
Three-dimensional structural analyses of human CEL
have shown that the enzyme belongs to the alpha/beta
hydrolase foldfamily with severalkey structuraland catalytic
features,including anactive site catalytic triad located within
the enzyme structure and partially covered by a surface loop,
the carboxyl terminus region of the protein which regulates
enzymatic activity by forming hydrogen bonds with the
surface loop to partially shield the active site, and a loop
domain which binds bile salt and frees the active site to
access water-insoluble substrates [1, 10, 36–38]. In both
conformations, CEL forms dimeric subunit structures with
active sites facing each other. The common variant of the
human CEL gene contains VNTR repeats, but there is a high
degree of polymorphism in the repeated region [31, 32].
While the biological function of the polymorphic repeat
region is unknown, it has been suggested that it may be im-
portant for protein stability and/or secretion of the enzyme,
particularly given that this region contains many O-glycosyl
bonds linking carbohydrate residues to the CEL C-terminus,
including fucose, galactose, glucosamine, galactosamine,
and neuraminic acid residues [39].
This paper reports the predicted gene structures and
amino acid sequences for several vertebrate CEL genes and
proteins, the predicted secondary and tertiary structures for
vertebrate CEL protein subunits, and the structural phylo-
genetic and evolutionary relationships for these genes and
enzymes with mammalian CES (carboxylesterase) gene fam-
ilies [40, 41].
2. Methods
2.1. Vertebrate CEL Gene and Protein Identiﬁcation. BLAST
(BasicLocalAlignmentSearchTool)studieswereundertaken
using web tools from the National Center for Biotechnology
Information(NCBI)(http://blast.ncbi.nlm.nih.gov/Blast.cgi)
[42]. Protein BLAST analyses used vertebrate CEL amino
acid sequences previously described (Table 1). Nonredun-
dant protein sequence databases for several mammalian gen-
omes were examined using the blastp algorithm, including
human (Homo sapiens)[ 43], chimp (Pan troglodytes)[ 44],
orangutan (Pongo abelii)( http://genome.wustl.edu/); the
cow (Bos Taurus)[ 45], horse (Equus caballus)[ 46], mouse
(Mus musculus)[ 47], opossum (Monodelphis domestica)
[48], platypus [49], chicken (Gallus gallus)[ 50], clawed toad
(Xenopus tropicalis)[ 51], and zebraﬁsh (Danio rerio)[ 52].
This procedure produced multiple BLAST “hits” for each of
the protein databases which were individually examined and
retainedinFASTAformat,andarecordkeptofthesequences
for predicted mRNAs and encoded CEL-like proteins. These
records were derived from annotated genomic sequences
using the gene prediction method: GNOMON and predicted
sequences with high similarity scores for human CEL [42].
Predicted CEL-like protein sequences were obtained in each
case and subjected to analyses of predicted protein and gene
structures.
BLAT (BLAST-Like Alignment Tool) analyses were
subsequently undertaken for each of the predicted vertebrate
CEL amino acid sequences using the University of California
Santa Cruz (UCSC) Genome Browser (http://genome.ucsc
.edu/cgi-bin/hgBlat)[ 4] with the default settings to obtain
the predicted locations for each of the vertebrate CEL genes,
including predicted exon boundary locations and gene sizes.
Structures for human, mouse, and rat CEL isoforms (splice
variants) were obtained using the AceView website (http://
www.ncbi.nlm.nih.gov/IEB/Research/Acembly/index.html
?human) to examine predicted gene and protein structures
[2]. Alignments of vertebrate CEL sequences with human
carboxylesterase (CES) protein sequences were assembled
using the ClustalW2 multiple sequence alignment program
[53]( http://www.ebi.ac.uk/Tools/clustalw2/index.html).
2.2. Predicted Structures and Properties of Vertebrate CEL
Protein Subunits . Predicted secondary and tertiary struc-
tures for vertebrate CEL-like subunits were obtained using
the PSIPRED v2.5 web site tools (http://bioinf.cs.ucl.ac.uk/
psipred/)[ 54] and the SWISS MODEL web tools (http://
swissmodel.expasy.org/), respectively [55, 56]. The reportedCholesterol 3
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tertiary structure for bovine CEL (PDB: 1aqlB) [1]s e r v e d
as the reference for the predicted human and zebraﬁsh CEL
tertiary structures, with a modeling range of residues 21 to
552. Theoretical isoelectric points and molecular weights for
vertebrate CEL subunits were obtained using Expasy web
tools (http://au.expasy.org/tools/pi tool.html). SignalP 3.0
web tools were used to predict the presence and location of
signalpeptidecleavagesites(http://www.cbs.dtu.dk/services/
SignalP/) for each of the predicted vertebrate CEL sequences
[57]. The NetNGlyc 1.0 Server was used to predict potential
N-glycosylation sites for vertebrate CEL subunits (http://
www.cbs.dtu.dk/services/NetNGlyc/).
2.3. Comparative Human (CEL) and Mouse (Cel) Tissue Ex-
pression. T h eU C S CG e n o m eB r o w s e r( http://genome.ucsc
.edu/)[ 4] was used to examine GNF1 Expression Atlas 2 data
using various expression chips for human CEL and mouse
Cel genes, respectively, (http://biogps.gnf.org/)[ 3]. Gene ar-
ray expression “heat maps” were examined for comparative
gene expression levels among human and mouse tissues
showing high (red), intermediate (black), and low (green)
expression levels.
2.4. Phylogenetic Studies and Sequence Divergence. Align-
ments of vertebrate CEL and human, mouse, and nematode
CES-like (carboxylesterase) protein sequences were assem-
bledusingBioEditv.5.0.1andthedefaultsettings[58].Align-
mentambiguousregionswereexcludedpriortophylogenetic
analysis yielding alignments of 480 residues for comparisons
of sequences (Table 1). Evolutionary distances were calcu-
lated using the Kimura option [59] in TREECON [60]. Phy-
logenetic trees were constructed from evolutionary distances
using the neighbor-joining method [61] and rooted with the
nematode CES sequence. Tree topology was reexamined by
the boot-strap method (100 bootstraps were applied) of res-
ampling, and only values that were highly signiﬁcant (≥90)
are shown [62].
3. Results andDiscussion
3.1.AlignmentsofHumanandOtherVertebrateCELSubunits.
The deduced amino acid sequences for opossum (Monod-
elphis domestica) and chicken (Gallus gallus) CEL subunits
and for zebraﬁsh (Danio rerio) CEL1 and CEL2 subunits
are shown in Figure 1 together with the previously reported
sequences for human (Homosapiens)[ 7, 39], mouse (Mus
musculus)[ 22], and bovine (Bostaurus)[ 27, 63]C E Ls u b u n -
its (Table 1). Alignments of the human and other vertebrate
CEL subunits examined in this ﬁgure showed between 56–
80% sequence identities, suggesting that these are products
of the same family of genes and proteins (Table 2). The
amino acid sequence for human CEL contained 756 residues
whereas other vertebrate CEL subunits contained fewer
amino acids: 599 residues (cow), 598 residues (mouse), 579
residues (opossum), 556 residues (chicken), and 550 res-
idues for zebraﬁsh CEL1 and CEL2 (Figure 1; Table 1). These
diﬀerences are predominantly explained by changes in the
number of VNTR 11 residue repeats at the respective CEL
C-termini, with human CEL containing 17 repeats, whereas
bovine, mouse, and opossum CEL C-termini contained only
3, 3, and 1 repeats, respectively, while chicken and zebraﬁsh
CEL subunits exhibited no VNTR-like C-terminus sequen-
ces. Table 1 summarizes this feature among all of the verte-
brate CEL sequences examined and shows that substantial
numbers of C-terminus VNTR repeats were predominantly
restricted to higher primates, especially gorilla (Gorilla
gorilla) (39 repeats) [20], human (17 repeats) [17], and rhe-
sus (Macaca mulatta) (15 repeats) CEL, whereas other
mammalian CEL subunits usually contained 3 VNTR re-
peats, with the exception of the predicted dog (Canis famil-
iaris) CELC-terminus, which contained 13 VNTR-repeat
sequences. A comparison of the 11-residue repeat sequences
for the mammalian CEL subunits examined showed the
following consensus sequence: Pro-Val-Pro-Pro-Thr-Gly-
Asp-Ser-Glu-Ala-Ala (Figure 2), for which the ﬁrst 4 res-
idues have been proposed to play a role in facilitating O-
glycosylation at the 5th residue (Thr) position [10].
Several other key amino acid residues for mammalian
CEL have been recognized (sequence numbers refer to
human CEL) (Figure 1). These include the catalytic triad
for the active site (Ser194; Asp320; His435) forming a
charge relay network for substrate hydrolysis [10, 64]; the
hydrophobic N-terminus signal peptide (residues 1–20) [7,
65]; disulﬁde bond forming residues (Cys84/Cys100 and
Cys266/Cys277) [7, 66]; arginine residues (Arg83/Arg446)
which contribute to bile-salt binding and activation [1,
36]; a heparin binding site (residues 21–121); as well as
the 11-residue VNTR repeat (×17) at the CEL C-terminus
(residues562–756).Identicalresidueswereobservedforeach
of the vertebrate CEL subunits for the active site triad,
disulﬁde bond forming residues and key arginine residues
contributing to bile salt activation, however, the N-terminus
20-residue signal peptide underwent changes in sequence
but retained predicted signal peptide properties (Figure 1;
Table 1). The N-glycosylation site reported for human CEL
at Asn207-Ile208-Thr209 [10] was retained for each of the
22 vertebrate CEL sequences examined, with the exception
of platypus (Ornithorhynchus anatinus)C E Lw h i c hc o n -
tainedtwopredictedN-glycosylationsitesatAsn381-Val382-
Thr383 and Asn548-Leu549-Thr550 (Table 3). Predicted N-
glycosylation sites were also observed at other positions,
including Asn381-Ile382-Thr383 for opossum (Monodel-
phis domestica) CEL; Asn270-Thr271-Thr272 and Asn381-
Leu382-Thr383 for chicken (Gallus gallus) CEL; Asn270-
Thr271-Thr272forlizard(Anoliscarolensis);Asn550-Val551-
Thr552 for fugu (Takifugu rupides)C E L( Table 3). Given
the reported role of the N-glycosylated carbohydrate group
in contributing to the stability and maintaining catalytic
eﬃciency of a related enzyme (carboxylesterase or CES1)
[67], this property may be shared by the vertebrate CEL
subunits as well, especially for those containing multiple
predicted sites for N-glycosylation, such as chicken CEL,
which contains three such sites.
3.2. Predicted Secondary and Tertiary Structures of Vertebrate
CEL Subunits. Analyses of predicted secondary structures6 Cholesterol
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β9
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Figure 1: Amino acid sequence alignments for human and other vertebrate CEL subunits. See Table 1 for sources of CEL sequences; ∗
shows identical residues for CEL subunits;: similar alternate residues;. dissimilar alternate residues; N-Signal peptide residues are in red;
N-glycosylation residues at 207NIT (human CEL) are in green; active site (AS) triad residues Ser, Asp, and His are in pink; O-glycosylation
sites are in blue; disulﬁde bond Cys residues for human CEL (•); essential arginines which contribute to bile-salt binding are in red; helix
(human CEL or predicted helix); sheet (human CEL) or predicted sheet; bold font shows known or predicted exon junctions; exon numbers
refer to human CEL gene; CEL “loop” covering the active site (human CEL residues 136–143) are in green; Hu-human CEL; Co-cow CEL;
Mo-mouse CEL; Op-opossum CEL; Ch-chicken CEL; Z1-zebraﬁsh CEL1; Z2-zebraﬁsh CEL2.
for vertebrate CEL sequences were compared with the pre-
viously reported secondary structure for bovine and human
CEL [1, 68]( Figure 1). Similar α-helix β-sheet structures
were observed for all of the vertebrate CEL subunits exam-
ined. Consistent structures were particularly apparent near
keyresiduesorfunctionaldomainsincludingtheβ-sheetand
α-helix structures near the active site Ser194 (β8/αD) and
Asp320 (β10/α8) residues, and the N-glycosylation site at
Asn207-Ile208-Thr209 (near β8) [69]. The single helix at the
C-termini (αN) for the vertebrate CEL subunits was readily
apparent, as were the ﬁve β-sheet structures at the N-termini
oftheCELsubunits(β1–β5).Itisapparentfromthesestudies
that all of these CEL subunits have highly similar secondary
structures.
Figure 3describes predicted tertiary structures for mouse
CEL and zebraﬁsh CEL1 protein sequences which showed
signiﬁcant similarities for these polypeptides with bovine
[1, 36]a n dh u m a nC E L[ 68]. Identiﬁcation of speciﬁc struc-
tures within the predicted mouse CEL and zebraﬁsh CEL1
sequences was based on the reported structure for a trun-
cated human CEL which identiﬁes a sequence of twisted β-
sheets interspersed with several α-helical structures [10, 68]
which are typical of the alpha-beta hydrolase superfamily
[40]. The active site CEL triad was centrally located which
is similar to that observed in other lipases and esterases
[40, 70, 71]. The major diﬀerence between CEL and other
serine esterases is an apparent insertion at positions 139–
146 (for human CEL) (Figure 1 of Supplementary Material
available online at doi 10.1155/2011/781643) which appears
to act as a surface loop that partially covers the opening to
the catalytic triad and allows access to the active site by water
soluble substrates by the truncated CEL [68]. This active
site loop is also readily apparent in the predicted structures
for mouse CEL and zebraﬁsh CEL1. These comparative
studiesofvertebrateCELproteinssuggestthattheproperties,
structures,andkeysequencesaresubstantiallyretainedforall
of the vertebrate sequences examined.
3.3. Predicted Gene Locations and Exonic Structures for Verte-
brateCELGenes. Table 1 summarizesthepredictedlocationsCholesterol 7
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Figure 2: Amino acid alignments for C-terminal 11-residue repeat sequences for mammalian CEL subunits. Hydrophobic amino acid
residues are shown in red; hydrophilic residues in green; acidic residues in blue; basic residues in pink; (squared T) refers to known O-
glycosylationsitesforhumanCEL;Rreferstorepeatnumber.P-proline;V-valine;T-threonine;G-glycine;D-aspartate;E-glutamate;S-serine;
A-alanine; K-lysine; N-asparagine; note consistent PVPP start sequences.
Table 3: Known or predicted N-glycosylation sites for vertebrate CEL subunits.
Vertebrate Site 1 Site 2 Site 3 Site 4 Site 5 Site 6 No of sites
CEL
Human 210NIT 1
Chimp 207NIT 1
Gorilla 210NIT 518NGS 1
Rhesus 207NLT 515NGS 1
Marmoset 207NIT 515NGS 1
Mouse 207NIT 325NNT 1
Rat 207NIT 1
Guinea pig 207NIT 1
Cow 207NIT 381NAT 1
Horse 207NIT 381NAT 515NSS 1
Dog 207NIT 381NST 567NAT 1
Opossum 207NIT 381NIT 2
Platypus 381NVT 548NLT 2
Chicken 207NIT 270NTT 381NLT 3
Lizard 207NIT 270NTT 2
Frog 207NIT 1
Zebraﬁsh 1 204NIT 1
Zebraﬁsh 2 204NIT 1
Puﬀerﬁsh 204NIT 1
Fugu 204NIT 550NVT 2
Stickleback 205NIT 1
Medaka 204NIT 1
The identiﬁed N-glycosylation site is for human CEL (see [10]). Amino acid residues are shown for known or predicted N-glycosylation sites: N-Asn; A-Ala;
T-Thr; S-Ser; M-Met; L-Leu; D-Asp; G-Gly; F-Phe; I-Ile; V-Val; sites with high probabilities for N-glycosylation are written in boldface.Cholesterol 9
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Figure 3: Predicted tertiary structures for mouse CEL and zebraﬁsh CEL1 subunits. The predicted mouse CEL and zebraﬁsh CEL1 3-D
structures were obtained using the SWISS MODEL web site http://swissmodel.expasy.org/ and based on the reported structure for bovine
CEL (PDB: 1aqlB) [1]; the rainbow color code describes the 3-D structures from the N- (blue) to C-termini (red color); N refers to amino
terminus; C refers to carboxyl terminus; speciﬁc alpha helices (αA...αN) and beta sheets (β1...β13) were identiﬁed, as well as the active
site region and the “loop” covering the active site.
for vertebrate CEL genes based upon BLAT interrogations of
several vertebrate genomes using the reported sequences for
human, gorilla, mouse, rat, and bovine CEL [6, 7, 20, 22–
24, 27] and the predicted sequences for other vertebrate CEL
proteins and the UCSC Genome Browser [4]. Human and
mouseCELgeneswerelocatedonhumanchromosome9and
mouse chromosome 2, which are distinct to the carboxyles-
terase (CES for human or Ces for mouse) gene family cluster
locationsineachcase:onhumanchromosome16andmouse
chromosome8,respectively(Table 1;see[41]).Thezebraﬁsh
(Daniorerio)genomeshowedevidenceoftandemduplicated
CEL genes, with predicted CEL1 and CEL2 genes being lo-
cated about 7.3 kilobases apart on zebraﬁsh chromosome
21 (Table 1). This is in contrast with many other gene du-
plication events during zebraﬁsh evolution that have oc-
curred predominantly by polyploidisation or duplication of
largechromosomalsegmentsratherthanbytandemgenedu-
plication [72].
Figure 1 summarizes the predicted exonic start sites for
cow, opossum, chicken, and zebraﬁsh CEL genes with each
having 11 exons, in identical or similar positions to those
reported for the human CEL and mouse Cel genes [17,
22, 23]. In contrast, human CES1 [73, 74], CES2, CES3
[75, 76], CES4 [41], and CES5 [77, 78] genes contained 14,
12, 13, 14, and 13 exons, respectively, which are predomi-
nantly in distinct positions to those described for vertebrate
CEL genes, with the exception of the last exon in each case
(Figure 1 of Supplementary Material). Consequently, even
though CEL and CES genes and proteins are members of the
sameserinehydrolasesuperfamily[10,40],itisapparentthat
CEL is not a close relative of the CES gene family, for which
at least ﬁve genes are clustered on a single chromosomes on
human and mouse chromosomes and are more similar in
gene structure to each other than they are to the CEL gene
(Figure 1 of Supplementary Material; see [41]).
Figure 4illustratesthepredictedstructuresofmRNAsfor
human and mouse CEL transcripts for the major transcript
isoform in each case [2]. The transcripts were 10.5 and
7.6 kilobases in length, respectively, with 10 introns and 11
exons present for these CEL mRNA transcripts. The human
CEL genome sequence contained a microRNA site (miR485-
5p) located in the 3 -untranslated region and a CpG island
(CpG51). The occurrence of the CpG island within the CEL
gene may reﬂect a role in regulating gene expression [79]
which may contribute to a higher than average gene expres-
sion level reported for human CEL (×1.5 times higher).
Figure 2 of Supplementary Material shows a nucleotide se-
quence alignment diagram for the CpG51 region of the
human CEL gene in comparison with several other mam-
malian and other vertebrate CEL genes. The Multiz align-
ment patterns observed demonstrated extensive sequence
conservation for the CpG island which contains dinucleotide
and trinucleotide repeat sequences in most genomes exam-
ined.
The prediction of a microRNA (miRNA; miR485-5p)
binding site in the 3 untranslated region of human CEL is10 Cholesterol
Human CEL
3 on plus strand ×1.5 expression level
3 on minus strand ×3.4 expression level
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5
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3UTR
3UTR
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Figure 4: Gene structures for the human and mouse CEL genes. Derived from AceView website http://www.ncbi.nlm.nih.gov/IEB/Research/
Acembly/ [2]; the major isoform variant is shown with capped 5 - and 3 - ends for the predicted mRNA sequences; introns and exons are
numbered; the length of the mRNAs (as kilobases or kb) and comparative expression levels with the average gene are shown; a CpG island
(CpG51); several predicted transcription factor binding sites; and a MiRNA485-5p binding site were identiﬁed for the human CEL gene; the
direction for transcription is shown; 3 U T Rr e f e r st o3  -untranslated region.
5UTR 3UTR
Exons
Tandem repeat region 
CEL
12 3 4 5 6 7 8 9 1 0 1 1
Figure 5: Comparative sequences for vertebrate 5 -ﬂanking, 5 -untranslated, and coding regions for the CEL genes. Derived from the UCSC
Genome Browser using the Comparative Genomics track to examine alignments and evolutionary conservation of CEL gene sequences;
genomicsequencesalignedforthisstudyincludedprimate(humanandrhesus),nonprimateeutherianmammal(mouse,dogandelephant),
a marsupial (opossum), a monotreme (platypus), bird (chicken), reptile (lizard), amphibian (frog), and ﬁsh (stickleback); conservation
measures were based on conserved sequences across all of these species in the alignments which included the 5 ﬂanking, 5 -untranslated
(5 UTR), exons, introns, and 3  untranslated (3 UTR) regions for the CEL gene; regions of sequence identity are shaded in diﬀerent colors
for diﬀerent species; exons 1–11 are shown which are regions of conservation.Cholesterol 11
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Figure 6: Comparative tissue expression for human and mouse CEL genes. Expression “heat maps” (GNF Expression Atlas 2 data)
(http://biogps.gnf.org/)[ 3] were examined for comparative gene expression levels among selected human (GNF1H) and mouse (GNF1M)
tissues for CEL showing high (red), intermediate (black), and low (green) expression levels. The results were derived from the human and
mouse genome browsers (http://genome.ucsc.edu/)[ 4].
alsopotentiallyofmajorsigniﬁcancefortheregulationofthis
gene. MicroRNAs are small noncoding RNAs that regulate
mRNA and protein expression and have been implicated in
regulating gene expression during embryonic development
[80].Moreover,arecentstudyofarelatedmiRNAgene(miR-
375) has been recently shown to be selectively expressed in
pancreatic islets and has been implicated both in the devel-
opment of islets and the function of mature pancreatic beta
cells [81]. A similar role may be played by miR485-5p with
respecttotheregulationofCELexpressionduringpancreatic
beta cell development. Table 1 of Supplementary Material
presents comparative nucleotide sequences for miR485-5p-
like CEL gene regions for several vertebrate genomes which
shows high levels of sequence identity, particularly among
mammalian CEL miRNA target sites and suggests that this
site has been predominantly conserved during vertebrate
evolution, particularly by eutherian mammalian CEL genes.
Figure 5 shows a UCSC Genome Browser Comparative
Genomics track that shows evolutionary conservation and
alignments of the nucleotide sequences for the human CEL
gene, including the 5 -ﬂanking, 5 -untranslated, intronic,
exonic, and 3 untranslated regions of this gene, with the cor-
responding sequences for 10 vertebrate genomes, includ-
ing 5 eutherian mammals (e.g., mouse, rat), a marsupial
(opossum), a monotreme (platypus), and lower vertebrate
genomes. Extensive conservation was observed among these
genomic sequences, particularly for the rhesus CEL gene and
for other eutherian mammalian genomes. In contrast with
the eutherian mammalian genomes examined, other ver-
tebrate genomes retained conserved sequences only within
the 11 exonic CEL regions. It would appear that exonic
CEL nucleotide sequences have been conserved throughout
vertebrate evolution whereas only in eutherian mammalian
genomes have other regions of the CEL gene been predomi-
nantly conserved.
3.4. Comparative Human and Mouse CEL Tissue Expression.
Figure 6 presents “heat maps” showing comparative gene ex-
pressionforvarioushumanandmousetissuesobtainedfrom
GNF Expression Atlas Data using the GNF1H (human) and
GNF1M (mouse) chips (http://genome.ucsc.edu/; http://bi-
ogps.gnf.org/)[ 3] .T h e s ed a t as u p p o r t e dah i g hl e v e lo f
tissue expression for human CEL, particularly for the pan-
creatic islets, the pituitary gland, and fetal liver, which is
consistent with previous reports for these genes (see [10]).
High levels of CEL gene expression have also been report-
ed for the human mammary gland where CEL plays a major
role in lipid digestion in breast milk by neonates [6].
The localization of CEL within the human pituitary gland is
of major interest as this enzyme also hydrolyzes ceramides
[8], which suggests a possible role in the regulation of
hormone secretion in both normal and adenomatous pi-
tuitary cells [16]. A high level of expression of CEL in
mouse tissues was also observed (×3.4 times average ex-
pression) (Figure 4),particularlyforthepancreas,mammary
gland, and spleen (Figure 5), where similar metabolic roles12 Cholesterol
10%
Elegans CES     
Platypus CEL     
Cow CEL     
Opossum CEL     
Marmoset CEL     
Rhesus CEL     
Guinea pig CEL     
Gorilla CEL     
Chimp CEL     
Human CEL     
Dog CEL     
Horse CEL     
Rat CEL     
Mouse CEL     
Frog CEL     
Chick CEL     
Zebraﬁsh CEL2    
Zebraﬁsh CEL1    
Stickleback CEL     
Medaka CEL     
Fugu CEL   
Pufferﬁsh CEL     
Mouse CES4a    
Human CES4     
Mouse CES1a    
Human CES1     
Mouse CES3a    
Human CES3     
Mouse CES5a    
Human CES5
Mouse CES2a    
Human CES2     
100
100
100
100
100
100
100
97
98
100
100
100
100
100
100
100
100
Figure 7: Phylogenetic tree of vertebrate CEL with human and mouse CES1, CES2, CES3, CES4, and CES5 amino acid sequences. The tree
is labeled with the gene name and the name of the vertebrate. Note the major cluster for the vertebrate CEL sequences and the separation
of these sequences from human and mouse CES1, CES2, CES3, CES4, and CES5 sequences. The tree is “rooted” with the CES sequence
(T27C12) from a nematode (Caenorhabditis elegans). See Table 1 for details of sequences and gene locations. A genetic distance scale is
shown (% amino acid substitutions). The number of times a clade (sequences common to a node or branch) occurred in the bootstrap
replicates are shown. Only replicate values of 90 or more which are highly signiﬁcant are shown with 100 bootstrap replicates performed in
each case.
for this enzyme in cholesterol ester, retinyl ester, and
triglyceride hydrolysis and metabolism have been described
[10]. Recent metabolic studies using Cel−/Cel− (knock-out)
mice (or CELKO mice) have demonstrated that CEL is not
an essential enzyme for these metabolic functions [82, 83],
although CELKO neonatal mice exhibit an incomplete diges-
tion of milk fat [9, 84], and in adult CELKO mice causes an
elevation in reverse cholesterol transport (RCT) in adult ani-
mals [14]. The latter ﬁnding is potentially of major clinical
signiﬁcance for this enzyme, given that any increase in RCT
and the associated increased biliary disposal of cholesterol
may contribute to preventing atherosclerosis [85, 86].
3.5. Phylogeny and Divergence of Vertebrate CEL and
Mammalian/Nematode CES Sequences. A phylogenetic tree
(Figure 7) was calculated by the progressive alignment of
human and other vertebrate CEL amino acid sequences with
human and mouse CES1, CES2, CES3, CES4, and CES5
sequences. The phylogram was “rooted” with a nematode
CES sequence and showed clustering of the CEL sequences
which were distinct from the human and mouse CES fam-
ilies. In addition, the zebraﬁsh CEL1 and CEL2 sequences
showed clustering within the ﬁsh CEL sequences examined,
which is consistent with these genes being products of a
recent duplication event during teleost ﬁsh evolution. Over-
all, these data suggest that the vertebrate CEL gene arose
from a gene duplication event of an ancestral CES-like gene,
resulting in at least two separate lines of gene evolution for
CES-like and CEL-like genes. This is supported by the com-
parative biochemical and genomic evidence for vertebrate
CEL and CES-like genes and encoded proteins, which share
several key features of protein and gene structure, including
having similar alpha-beta hydrolase secondary and tertiary
structures [10, 40, 41, 71, 78] (Figure 1 of Supplementary
Material).
In conclusion, the results of the present study indicate
that vertebrate CEL genes and encoded CEL enzymes repre-
sent a distinct alpha-beta hydrolase gene and enzyme family
which share key conserved sequences and structures that
have been reported for the human CES gene families. CEL
is a major triglyceride, cholesterol ester and vitamin ester
hydrolytic enzyme contained within exocrine pancreatic and
lactating mammary gland secretions and is also localized in
plasma where it contributes to chylomicron assembly andCholesterol 13
secretion, in the selective uptake of cholesteryl esters in HDL
in the liver and in reverse cholesterol transport, including
biliary disposal of cholesterol. Bioinformatic methods were
used to predict the amino acid sequences, secondary and
tertiary structures and gene locations for CEL genes, and
encoded proteins using data from several vertebrate genome
projects. A proline-rich and O-glycosylated 11-amino acid
C-terminal repeat sequence (VNTR) previously reported for
human and other higher primate CEL proteins was also ob-
served for other eutherian mammalian CEL sequences ex-
amined. Opossum CEL, however, contained a single C-
terminal copy of this sequence while CEL proteins from
lower vertebrates lacked the VNTR sequence. Evidence is
presented for tandem duplicated CEL genes for the zebraﬁsh
genome. Vertebrate CEL protein subunits shared 53–97%
sequence identities and exhibited sequence alignments and
identitiesforkeyCELaminoacidresiduesaswellasextensive
conservation of predicted secondary and tertiary structures
with those previously reported for human CEL. Phylogenetic
analyses demonstrated the relationships and potential evolu-
tionary origins of the vertebrate CEL family of genes which
were related to a nematode carboxylesterase (CES)g e n ea n d
ﬁve mammalian CES gene families. These studies indicated
that CEL genes have apparently appeared early in vertebrate
evolution prior to the teleost ﬁsh common ancestor more
than 500 million years ago [87].
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